what are glp-1 Glucagon-like peptide-1 Targeting GLP-1, GIP & GCG
Description
[DOI] [PubMed] [Google Scholar] 38.Sundby F., Jacobsen H., Moody A.J
The research on subtherapeutic doses is limited, and long-term effects remain unknown
The STEP 1 study evaluated the effects of Wegovy in people with a BMI of 27 or higher and found that participants using Wegovy lost an average of 12.4% more weight than those in the placebo group
Better cholesterol means a healthier heart
Beyond glucose control and weight reduction, GLP1RAs were shown to reduce cardiovascular morbidity and mortality and are therefore strongly recommended in early lines of diabetic therapy [3, 4]
[DOI] [PMC free article] [PubMed] [Google Scholar] 13.Lee S.-O., Kuthati Y., Huang W.-H., Wong C.-S
